Global Tylosin Market Growth 2023-2029

Global Tylosin Market Growth 2023-2029

Tylosin is a macrolide-class broad spectrum antibiotic that’s used in veterinary medicine to treat felines, canines and livestock. However, the drug is only used as an antibiotic in the treatment of infections in livestock. In cats, dogs, and other smaller animals, it is used predominantly for its anti-inflammatory properties to treat inflammatory conditions in the bowel. As such, it is commonly prescribed to pets that are suffering from diarrhea.
LPI (LP Information)' newest research report, the “Tylosin Industry Forecast” looks at past sales and reviews total world Tylosin sales in 2022, providing a comprehensive analysis by region and market sector of projected Tylosin sales for 2023 through 2029. With Tylosin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tylosin industry.
This Insight Report provides a comprehensive analysis of the global Tylosin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tylosin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tylosin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tylosin and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tylosin.
The global Tylosin market size is projected to grow from US$ 674.4 million in 2022 to US$ 909 million in 2029; it is expected to grow at a CAGR of 909 from 2023 to 2029.
Elanco, Huvepharma, Tairui, Lukang Shelile and Qilu Pharmaceutical are the main players in this industry. Tairui was considered the leader of the global market, accounting for 43% of the sales volume.
The global Tylosin market is led by Asia Pacific. Europe is the second-largest region-wise market.
This report presents a comprehensive overview, market shares, and growth opportunities of Tylosin market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Tylosin Tartrate
Tylosin Phosphate
Segmentation by application
Animal Feed Additives
Animal Drugs
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Elanco
Huvepharma
Tairui
Lukang Shelile
Qilu Pharmaceutical
Top Pharm Chemical Group
HISUN
Apeloa
Key Questions Addressed in this Report
What is the 10-year outlook for the global Tylosin market?
What factors are driving Tylosin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Tylosin market opportunities vary by end market size?
How does Tylosin break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.